Canadian CANNAINVESTOR Magazine April 2017 - Page 58

Retail Investor's Perspective

CannWay Pharma: 100%

Canabo Medical: 16.6% initial investment (6 million *shares) - 500K shares (8.3% of holdings) reported sold *subsequently.

CannaRoyalty: > 7.2%

Copperstate Farms: 10% - 15%

Green Acre Capital: Pledged $2 million into the fund *that is expected to have $30 million. Aphria CEO Vic *Neufield is an advisor.

MassRoots: All shares reported by third part as sold but *retains warrants.

Resolve Digital Health: 4.8% plus options

Scythian BioSciences: Effected through a reverse *takeover of Kitrinor Metals but Aphria named the lead *investor.

Tetra Bio-Pharma: Another company referenced in an *early article and included in the monthly ROI chart. *Aphira invested $1 million for 5 million shares and also *received 5 million warrants with a $0.26 strike price. *Subsequent to that initial investment, TBP shares *reached a $1.48 high.

On February 27, 2018 ran a headline asking “Can Aphria Inc. Challenge Canopy Growth Corp’s Dope Dominance?” A March 2, 2017 article opened with Aphria “is an interesting stock. If there was a Blue Chip segment of the cannabis patch, this would be the stalwart best-in-class (or close to it). (APHRIA-BLUE CHIP).